News
-
-
PRESS RELEASE
Cantourage welcomes clarification on the implementation of the German GKV-FinStG
Cantourage Group SE welcomes clarification on the implementation of the German GKV-FinStG by KBV and GKV-Spitzenverband, ensuring continuity of treatment with cannabis extracts. CEO Philip Schetter emphasizes legal certainty benefits for patients and physicians -
-
PRESS RELEASE
Original-Research: Cantourage Group SE (von First Berlin Equity Research GmbH): Kaufen
First Berlin Equity Research reaffirms BUY rating on Cantourage Group SE with €11 target price after the launch of 'gramz.' proprietary product for the German MedCan market. Strategic shift to direct sourcing for higher margins -
-
-
-
-
-
PRESS RELEASE
Cantourage Group SE // Cantourage Significantly Increases Profitability in the First Quarter of 2026
Cantourage Group SE significantly increases profitability in the first quarter of 2026 driven by premium products and international expansion, with revenue growth and solid financial position